巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Eagle Pharmaceuticals

    EGRX
    35.830
    0.230
    0.65%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Eagle Pharmaceuticals - 延遲價格・最後更新於 15/08 9:30
    最高位
    36.040
    最低位
    35.140
    開市價
    --
    前收市價
    35.600
    成交量(千)
    5.05
    成交額(百萬)
    1.64
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    475.99
    市盈率
    20.240
    息率
    --
    差價
    --
    52週高低
    58.250 - 33.717
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Eagle Pharmaceuticals
    證券代碼
    EGRX.US
    所屬板塊
    Drug Manufacturers - Specialty & Generic
    公司業務
    Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration.
    發行量
    13284559
    公司總部
    50 Tice Boulevard, Suite 315
    公司網址
    http://www.eagleus.com
    公司電郵
    info@eagleus.com
    公司電話
    +1 201 326-5300
    暫無內容

    關於

    Eagle Pharmaceuticals(EGRX.US)所屬的行業板塊為Drug Manufacturers - Specialty & Generic。
    Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration.
    詳細公司背景可參考: http://www.eagleus.com